NCT03474523

Brief Summary

The aim of the present study is to value the effectiveness of Diathermy-Radiofrecuency treatment compared to Cavitation treatment in woman with cellulitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 22, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2020

Completed
Last Updated

March 13, 2020

Status Verified

March 1, 2020

Enrollment Period

2.4 years

First QC Date

February 8, 2018

Last Update Submit

March 12, 2020

Conditions

Keywords

radio frequency diathermycavitationultrasoundedemato-fibrosclerotic panniculopathycellulitis

Outcome Measures

Primary Outcomes (1)

  • Decrease in perimeter measures

    measuring tape

    At the begining and at the end of the treatment after seven weeks

Secondary Outcomes (4)

  • Changes in body mass index

    At the begining and at the end of the treatment after seven weeks

  • Changes in weight

    At the begining and at the end of the treatment after seven weeks

  • Physical activity evaluation

    At the begining and at the end of the treatment after seven weeks

  • Degree of cellulitis

    At the begining and at the end of the treatment after seven weeks. This scale measures the level of cellulite and takes the values of 0-3, being 0 the value where there is no cellulite and 3 the most serious stage of cellulite.

Study Arms (2)

Experimental or Diathermy-Radiofrecuency

EXPERIMENTAL

All patients are given a Combined Physiotherapy Protocol (CPP) consisting of: Diathermy-Radiofrecuency (manual 70% intensity of about 40-43º resistive modality for about 30 minutes and authomatic capacitive modality for about 10 minutes) and application of Presotherapy (intensity 35%, compression 35seg, pause 15 seg, speed 9, for about 30 minutes). Non-invasive treatment

Other: Experimental group

Control or Cavitation

ACTIVE COMPARATOR

All patients are given a Combined Physiotherapy Protocol (CPP) consisting of: Cavitation (plane electrode for about 30 minutes and focal electrode for about 10 minutes) at 70% intensity and application of Presotherapy (intensity 35%, compression 35seg, pause 15 seg, speed 9, for about 30 minutes). Non-invasive treatment

Other: Control group

Interventions

Cavitation: 70% intensity, 30 minutes apply plane electrode and 10 minutes focal electrode. Presotherapy: 30 minutes application of 35% intensity, compression 35seg, pause 15seg, speed 9

Experimental or Diathermy-Radiofrecuency

Diathermy-Radiofrecuency: 30 minutes at 70% intensity (40-43ºC) in manual resistive modality and 10 minutes in automatic capacitive modality. Presotherapy: 30 minutes application of 35% intensity, compression 35seg, pause 15seg, speed 9

Control or Cavitation

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPEFE has a greater incidence within women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female
  • UCA comunity
  • Age 18-40 years
  • Cellulite grade I, II, III (Nürnberg\&Müller clasification)
  • Compliance of study timing
  • Acceptance of informed consent and signature of study authorization

You may not qualify if:

  • Pacemaker, heart diseases, epilepsy,
  • pregnancy, lactation, last year postpartum, menstrual cycle alterations, climacteric, perimenopause
  • chronic disease, hormonal or circulatory disorder, neoplasia process
  • inflammation, infection, active acne, open wound in the treatment area
  • BMI above 27 Kg/m2, obesity, lipoedema, oedema, circulatory problems
  • Metal implants, prosthesis, intrauterine devices
  • Evolutive diseases
  • Severe Artheryal hipertension
  • High cholesterol levels or non-controlled triglycerides
  • Weight fluctuation above 2 kg in the last six months
  • Drinking more than two daily alcoholic drinks
  • Pharmacological treatment during study: anti-inflammatory, esthetical, cosmetical or dietetic treatment
  • Previous treatment of the studies areas in the last year
  • Surgery intervention in studies areas

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing and Physiotherapy. University of Cadiz

Cadiz, 11008, Spain

Location

MeSH Terms

Conditions

Cellulitis

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Skin Diseases, InfectiousInfectionsSuppurationConnective Tissue DiseasesSkin and Connective Tissue DiseasesInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Carmona I. Barrientos, Dra

    University of Cadiz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
external evaluator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled longitudinal experimental study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 8, 2018

First Posted

March 22, 2018

Study Start

October 20, 2017

Primary Completion

March 11, 2020

Study Completion

March 11, 2020

Last Updated

March 13, 2020

Record last verified: 2020-03

Locations